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Abstract
This report details the results of an ongoing project to engineer a mutant form of Red Fluorescent
Protein (RFP) variant mCherry that acts as a real-time in vivo protease sensor. The sought-after
mutant only becomes fluorescent when exposed to Tobacco Etch Virus (TEV) Protease, this
system’s model protease. This will be accomplished via the insertion of the TEV Protease
Recognition Site (TEV-PRS) in such a position that, before cleavage, will prevent the protein
from folding to fluorescent conformation, but upon cleavage, will allow for fluorescent
conformation to occur. The cylindrical structure of the protein, composed of beta-pleated sheets,
contains “loops” connecting these sheets, was analyzed, and sixteen sites were identified within
these loops as candidates for insertion sites of the TEV-PRS. Using Site-Directed Mutagenesis
(SDM) and Overlap-Extension Polymerase Chain-Reaction (OE-PCR), insertion at twelve of the
identified sites has been attempted, two of which have been expressed in surface display yeast,
digitally imaged, and their initial (pre-cleavage) fluorescence has been quantified. Four of the
intended sites were successfully mutated, in addition to one accidental site. While the sought
after mutant has not yet been identified, the results at this stage indicate promise, and further
study is recommended and will be carried on in the future by other Research Assistants.
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Introduction and Theory
Sensing protein activity in vivo is a great challenge. While protein assays can be performed upon
the spilled contents of lysed cells to find concentrations, this requires that the cells die. These
assays, as a result, only roughly reveal the protein concentration at the time of lysis, not over
time. In the case of prokaryotes or single-celled eukaryotes, groups of cells can be carried
through the same conditions and made to lyse at different times, generating a profile of
concentration over time. This process, however, is cumbersome, and introduces a possible source
of error in the presence of a lytic agent; it may cause degradation or misfolding of the proteins of
interest. Additionally, in the case of multicellular eukaryotes such as animals, this strategy
becomes increasingly difficult to implement due to the complex nature of the organisms.
Therefore, a non-invasive method of detecting protein activity in real time would be a highly
useful tool for investigation of gene expression and protein function, especially in plants and
animals. Perhaps the most significant advantage, however, would be the ability to detect protein
activity in living organisms, either unicellular or multicellular. One such signaling method would
be fluorescence. Light, unlike other signaling agents, can travel harmlessly through cells and can
be easily detected, and even quantified, by photovoltaic sensors.
One particular example of a use for these sorts of sensors would be in detecting the real-time
activity of certain proteases in Drosophila melogaster, a common fruit fly. This multicellular
organism is of great interest in the study of multicellular genetics, as, similar to Escherichia coli
among bacteria, Drosophila has been studied in great detail relative to other animals, and the
understanding of its gene expression is relatively deep. One major gap in understanding,
however, is the genetic and physiological mechanism behind ovulation [1]. Certain proteases are
speculated to be involved [2]. The ability to sense the presence of these proteins in real time
could potentially elucidate their role in the ovulation process, shedding great light on the species,
and multicellular organisms in general [3]. Due to the suspected involvement of a protease in
Drosophila ovulation, this mystery could be a prime candidate for the application of a
fluorescent protease sensor system in vivo.

Figure 1; Visualization of the mCherry secondary and tertiary structure generated in PyMOL with an Educational License, with
the color gradient from N to C terminus.
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In designing such a system, the fluorescent molecule selected should be optimized for the
application; in this case, fluorescence must be detectible from within the organism. A few
varieties of fluorescent proteins occur in nature. The most well-known is likely Green
Fluorescent Protein (GFP), derived from jellyfish. The protein is made up of a “barrel” shape
constructed from beta-pleated sheets, as well as a fluorescent core made up of several alpha
helices. Another variety is known as dsRed, derived from coral-reef organisms [4]. While similar
in structure, the wavelengths of light emitted are at the lower-frequency end of the visible
spectrum. This is ideal for in vivo detection within organisms, as longer wavelengths of light can
more effectively pass through tissue. This heterodimeric protein has been mutated, [4] generating
variants with different fluorescent wavelengths, one of which is a monomer called mCherry.
mCherry is a monomeric protein capable of emitting peak fluorescence at a wavelength of 610
nm [5]. Due its exceptionally high photostability and maturation rate, and low bleaching rate, is
an excellent candidate for use as a signaling agent. [6]
An important factor for use as a signaling agent is that the mechanism of initiating signaling
should not be transcriptional. The reason for this is that, were this the case, sensing would
depend upon gene expression, which is very difficult to predict in multicellular eukaryotes.
Additionally, a very high concentration of the protein being monitored would need to accumulate
in order for detection to be possible, meaning that if the protein is only active at very low
concentrations, the fluorescence would not be sufficient. A more significant issue with
expressional signaling is that expression can take hours to occur at a level sufficient for
detection. This time delay makes real time detection impossible.
As an alternative, the mCherry protein will be engineered into a protease sensor. The goal of this
project will be to create a protein which is naturally non-fluorescent, but becomes fluorescent in
the presence of a protease via recognition-site-cleavage. This will be accomplished by inserting
DNA coding for recognition site for the Tobacco Etch Virus Protease, or TEV Protease at
various spots or “Insertion Sites”. Criteria for the site are as follows:
• Must be between codons, such that all codons in the mCherry gene and TEV Protease
Recognition Site (TEV-PRS) remain intact and no frameshift mutations occur.
• Must not disturb the secondary structure of the mCherry protein, by breaking up any
beta-sheets or alpha-helices, as this would irreparably damage the structure.
• Must be present on the surface of the roughly cylindrical protein structure, such that the
protease will be able to access the recognition site.
mCherry is also optimal for TEV-PRS insertion for the reason that it is a monomeric protein, so
impacting oligomerization behavior with insertions is not a concern.
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Figure 2; Visual map of mCherry structure wherein arrows represent 𝛽-pleated sheets and cylinders represent 𝛼-helices.

As a result of these restrictions, the sites will be present in the loops which connect the betasheets with each other and also the fluorescent core at the top and bottom of the protein. The
behavior of the protein and the function of the inserted recognition site will be as follows: the
inserted sequence will initially cause the protein to be unable to fold into a fluorescent
conformation by “blocking” this formation. The presence of TEV, even at low concentrations,
will lead to virtually instantaneous cleavage of these sites, allowing the proteins to come together
and fluoresce, without otherwise impacting the behavior or metabolism of the cell.

Methods and Materials
Various kits, enzymes, cells, DNA and plasmids, and lab equipment were employed throughout
the lab work that went into this thesis.

Enzymes
Phusion High-Fidelity DNA polymerase from Thermo-Scientific was used for all PCR reactions,
and performed all in vitro DNA amplification in-lab. Similarly to Taq polymerase, Phusion
operates optimally at high temperatures (72°C), but has 52x fidelity.
T4 DNA Ligase was used for ligation reactions to “repair nicks” in DNA; in other words, the
ligase catalyzes the formation of phosphodiester bonds to join adjacent nucleotides (connected
by complementary “sticky ends at restriction sites, for example).
DpnI [7] is a restriction enzyme which is used for digesting methylated DNA. Methylation, being
a tool used for in vivo gene expression, would only be present in DNA produced in vivo, but not
synthetic DNA produced via PCR.
The High-Fidelity versions of NheI and BsrGI restriction enzymes were used to cleave an insert
containing the yo-mCherry gene from plasmids.

Figure 3; Cleavage sites for BsrGI-HF (left) and NheI-HF (right) from New England Bio Labs
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Cells
The bacterial cells used in plasmid amplification were TOP10 strain E. coli cells from
Invitrogen. These cells were selected for their high transformation efficiency (1x109 CFU/g
plasmid) and chemical competence, which make them ideal for high efficiency cloning and
plasmid propagation. Chemical competence is achieved by treating the cells with calcium
chloride to facilitate plasmid DNA attachment to the cell membrane, increasing transformation
efficiency. The cells lack antibiotic resistance, and allow for stable replication of plasmids with
high copy number.
The yeast cells used in fluorescence expression tests for the mutated mCherry genes were
EBY100 strain Saccharomyces cerevisiae, a strain of yeast optimized for surface display. The
strain contains the GAL operon, and also an insertion of AGA1 regulated by GAL. AGA1 codes
for the anchorage subunit of a-agglutinin, which embeds in the cell wall of molecules, and allows
for the surface presentation of AGA2 linked . This means that in the presence of galactose as a
carbon source, AGA1 and other GAL-linked genes are expressed.

DNA/Genetic Data
The gene coding for the protein of interest, mCherry, was a preexisting yeast-optimized variant.
While the resulting amino-acid sequence is the same, the codons are optimized based upon the
codon tRNA bias within the yeast genome.
The two plasmids employed in this research project were pN3 [8] and pCT302 [9].

Figure 4; Plasmid maps of pCT302 (left) and pN3 (right) from addgene

pCT302 is a yeast expression plasmid which is just over 6.1 kb in size without the insertion. It
contains the gene for Ampicillin resistance, as well as that for yeast Tryptophan synthase.
pCT302 also contains a GAL promoter and AGA2 linked to the insertion site, so when
transformed into EBY100 yeast and induced by presence of galactose, the insert-aga2 complex
disulfide bonds to the aga1 complex on the yeast surface and can be detected outside the cell.
pN3 is a mammalian expression plasmid just under 4kb in size without an insert. It contains the
gene for Kanamycin resistance.
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Mutation
Two methods, Site Directed Mutagenesis (SDM), and Overlap Extension Polymerase-Chain
Reaction (OE-PCR) were employed to perform the insertion mutation. Both methods used the
same plasmids, and had the same end result, but each had different requirements and procedures.
Site Directed Mutagenesis (SDM)
The first of two mutagenesis techniques employed was Site-Directed Mutagenesis (SDM). The
technique requires 2 complementary oligonucleotides to act as primers. Starting from the 5’ end,
the oligonucleotides must include roughly 20 base pairs upstream of the insertion point, followed
by the insertion sequence, followed by roughly 20 base pairs downstream. The reaction solution
is prepared to contain 10 pmol of each oligonucleotide primer, 50 ng template plasmid, 10 𝜇L
5X reaction buffer (containing various buffers, BSA, and detergent to ensure proper polymerase
function), 1 𝜇L dNTP to fuel synthesis of DNA, and 0.5 𝜇L Phusion DNA polymerase, made up
to a volume of 50𝜇𝐿 with ddH2O. It is important to keep the solution and all components on ice
up until it is placed into the thermal cycler to prevent denaturation of the polymerase.
The thermal cycle, as depicted in Figure 5B, begins with 1 minute of denaturation phase at 95°C
before beginning the 280 second cycle of denaturation-annealing-extension. The denaturation
phase is also run at 95°C so that all dsDNA separates to allow primers to bond during the
annealing phase. The 50 second annealing phase is run at 65°C, allowing primers to bond to the
template plasmids (as shown in the first phase of Figure 5A). The 180 second extension phase is
run at 72°C, and at this point the Phusion DNA polymerase attaches to the primers which are
bonded to the template plasmid and extends the plasmids in the 3’ direction around the circular
plasmid until it encounters the 5’ end of the plasmid being extended, where it detaches. The
extension phase for this SDM cycle is longer than that for a standard PCR cycle. This is because
the polymerase must extend the primer around the entire template plasmid, more than 4kb. The
SDM reaction cycles 18 times, and does not propagate exponentially in the way that PCR does.
At the conclusion of the 18th cycle, 5 additional minutes are allowed for extension, and then the
products are held indefinitely at 4°C, where they can be safely stored for 1-2 days.

A
+Phusion DNA polymerase
SDM Phusion thermal cycling

B
Figure 5; A; Visual representation of Site-Directed Mutagenesis used for
insertion, derived from Geiser et al. [10]. The segmented loop represents the
template plasmid (which is methylated, as it was synthesized in vivo), while
the thick black segment represents the insertion. The primers are extended
from the 3’ end along the template DNA until termination at their own 5’ end,
resulting in a complete, nicked plasmid with the insertion, which is
unmethylated since it was synthesized in vitro. Overnight digestion in DpnI
restricts only the methylated DNA, leaving only the mutated plasmid to be transformed into E. coli and amplified. B; Thermal
cycle diagram of “sdm phusion” cycle used for Site-Directed Mutagenesis. The cycle begins with a 60 second denaturation phase
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at 95°C, followed by a cycle of 50 second denaturation phase at 95°C, 50 second annealing phase at 65°C, and 180 second
extension phase at 72°C. This 3-part cycle repeats itself 18 times, followed by an additional 300 second extension phase at 72°C,
after which the cycler holds at 4°C indefinitely (not shown).

Following the thermal cycling, the SDM products must undergo DpnI restriction digest to
remove all methylated template DNA. Each sample must recived 1 𝜇𝐿 of DpnI, and must
incubate overnight (for at least 8 hours) at 37°C. The digested products can then be transformed
into TOP10 Competent E. coli cells for amplification, and the cells miniprepped to yield mutant
plasmid.
Overlap Extension PCR (OE-PCR)
The second Mutagenesis technique employed was Overlap Extension Polymerase Chain
Reaction, (OE-PCR). The technique requires 4 oligonucleotide primers; 2 mutagenic primers
(same as those used for SDM) and additionally 2 flanking primers. Additionally, the technique
requires 2 separate PCR reactions carried out in parallel, followed by a second round PCR
reaction. The reacting solution is prepared in much the same way was described for SDM; the
key variables are the primers used and the template dsDNA used. 10 pmol of each primer, 50 ng
template plasmid, 10 𝜇L 5X reaction buffer, 1 𝜇L dNTP, and 0.5 𝜇L Phusion DNA polymerase
are made up to a volume of 50𝜇𝐿. The thermal cycle used is that illustrated in Figure 6B.
The first round of PCR pairs the forward flanking primer with the reverse mutagenic primer
(Figure 6A a + b respectively) for one reaction, and the forward mutagenic primer with the
reverse flanking primer (Figure 6A c + d respectively). These PCR reactions are independently
carried out with the template DNA to produce two independent dsDNA products (Figure 6A AB
and CD), which overlap with each other over the region of the mutagenic primers. The products
must undergo gel purification and recovery to isolate the dsDNA PCR products. In the second
round of PCR, the products for both previous PCR reactions must be included as template DNA.
1 𝜇𝐿 of each product, in addition to both flanking primers, are included in this reacting solution.
The remainder of the solution should be prepared in the same way as the first PCR. This second
round of PCR should be performed in duplicate in order to ensure enough product is produced.

B
Figure 6; A; Visual representation of OE-PCR used for insertion, derived from
Heckman et al. [11]. The double stranded DNA at the top represents the
template DNA, a + d are flanking primers, and c + b are mutagenic primers.
Flanking primer a pairs with mutagenic b, which are used together in the
first round PCR reaction to make double stranded DNA fragment AB. Likewise, c + d pair to make CD. For the second round PCR
reaction, dsDNA fragments AB and CD are combined along with flanking primers a + d. Denatured AB ssDNA anneals to the
complementary CD region containing the insertion, and the fragments are extended to produce the final product of AD with the

A
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insertion. B; Thermal cycle diagram of “pcr ykc” cycle used for both steps of Overlap-Extension PCR. The cycle begins with a 5
minute denaturation phase at 95°C, followed by a cycle of 30 second denaturation phase at 95°C, 30 second annealing phase at
55°C, and 45 second extension phase at 72°C. This 3-part cycle repeats itself 30 times, followed by an additional 300 second
extension phase at 72°C, after which the cycler holds at 4°C indefinitely (not shown)

Following gel purification of the second round PCR products, the double stranded DNA can be
sequenced, ligated into a backbone, and expressed.

Heat-Shock Plasmid Transformation into Bacteria
For bacterial amplification of plasmids, Invitrogen TOP10 E. coli competent cells were used.
The cells were first removed from the -80°C freezer and allowed to thaw on ice. 4 𝜇𝐿
𝛽mercaptoethanol were added per 100 𝜇𝐿 cells in order to increase transformation efficiency by
degrading cell surface hydrocarbons [12]. The cells were allowed to incubate for 10 more
minutes on ice. For each transformation, 20 𝜇𝐿 of cells were added to 2 𝜇𝐿 of DpnI digested
plasmid product in chilled microfuge tubes, which were then gently mixed and incubated on ice
for 30 minutes. For the actual heat shock, the tubes were submerged in a 42°C water bath for 30
seconds and then placed back on ice for 2 minutes. In a BioSafety cabinet, 300 𝜇𝐿 37°C
preheated SOC media were added to each tube, which were then incubated in a shaker at 37°C
for 40 minutes. Again in the Biosafety cabinet, 150 𝜇𝐿 of each tube were added to a tube
containing 3-5 mL LB media with antibiotics (depending upon plasmid; ampicillin for pCT,
kanamycin for pN3). This ensures that only transformed cells can grow. These tubes were then
shaken and incubated overnight at 37°C. The following day, 20 𝜇𝐿 were plated under the
Biosafety hood on LB with the same antibiotic as before, and incubated upside down overnight.
More than 100 colonies are expected from this procedure, and less than 5 constitutes cause for
concern. Colonies were picked and miniprepped to yield amplified primers.

Yeast Growth and Induction for Surface Display
Successfully transformed surface display yeast (EBY100) with pCT302 was inoculated in the
Biosafety Cabinet into 3-5 mL SD-CAA media (a synthetic, minimal medium with glucose as a
carbon source, casamino acids, and deficient in both tryptophan and uracil). TRP1 acts as the
selection marker, since tryptophan synthetase allows growth on a tryptophan-deficient marker.
This inoculated sample was incubated for 24 hours at 30°C (no more than 72 hours). (The cell
𝑐𝑒𝑙𝑙𝑠
density should be between 107 and 108 𝑚𝐿 after growth, corresponding to an optical density of
around 𝑂𝐷600 ~ 1 𝑡𝑜 10.) These cells were centrifuged and he supernatant discarded. The grown
cells, now ready for induction, were diluted with SG-CAA to an optical density of 𝑂𝐷600 ~ 1
and resuspended. SG-CAA media is identical to SD-CAA, except galactose replaces glucose as
the carbon source. These samples was incubated at 20°C for at least 20 hours, but no more than
48. After a brief diauxic shift, the GAL operon will become active, and the GAL 1-10 promoter
on the pCT302 present will be transcribed. Being that yeast are eukaryotes capable of posttranscriptional control of gene expression, the genes present in pCT are transcribed and
translated to produce a hybrid protein of mutant mCherry and aga2. At the same time, the GALlinked AGA1 gene in the yeast DNA is also expressed. The aga1 complexes via disulfide bonds
with the aga2-mCherry complex, which then embeds in the cell wall of the cells, and can be
detected and measured.
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Results
Insertion Site Identification
Drawing from Pavoor et al., successful insertion mutations can be made between residues
interconnecting the 𝛽-pleated sheets comprising the barrel-structure [13]. The two insertion sites
utilized in Pavoor et al. are present at Asp-102/Asp-103 and at Glu-172/Asp-173, as illustrated in
Figure 5B, and it has been demonstrated that GFP can retain its fluorescence when insertions of
various lengths can be made here.
While GFP and mCherry have notably different amino acid sequences (refer to Figure 5A), their
barrel-and-core structures are very similar (refer to Figure 5B and 5C).
The crystal structure of mCherry was analyzed in PyMol, and new insertion sites were sought
between residues that:
a) Connect β-pleated sheets comprising the barrel-structure with each other as well as the
interconnecting the 𝛼-helices comprising the fluorescent core, as all of these sites occur
on the edges of the barrel structure similarly to those employed in Pavoor et al., and
b) Are not themselves a part of any secondary structure, so as not to disturb fluorescence or
overall structure irreparably.

A

mCherry
GFP

#

B

@

C

Figure 7; A; an amino acid sequence alignment of GFP to mCherry performed with EBI’s webPRANK, B; Visual map of secondary
structure for Green Fluorescent Protein annotated with residue numbers at identifying points in secondary structure [14] and
Pavoor et al. insertion sites at Asp-102/Asp-103 and at Glu-172/Asp-173 indicated with an ‘@’ and a '#’, respectively, C; Visual
map of secondary structure for mCherry Protein annotated with numbered and labeled (plain black text) residues at identifying
points in secondary structure as well as with the numbered (in black circles) and labeled (red text) original sixteen insertion sites.
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The destruction of a beta-pleated-sheet would make proper tertiary conformation impossible, and
that of an alpha helix could fundamentally alter or destroy fluorescence. Sixteen such sites were
identified. They are indicated in Figure 5C, as well as tabulated in Table 1. For shorthand, each
of the 16 sites was called MC??, wherein ?? was the 2-digit form of the insertion site number.
Table 1; Insertion sites MC01-MC16 paired with their positions, derived from the map in Figure 6

Insertion
MC01
MC02
MC03
MC04
MC05
MC06
MC07
MC08
MC09
MC10
MC11
MC12
MC13
MC14
MC15
MC16

Site
Y53/E53
K65/G66
E104/G105
D116/G117
D130/G131
S146/D147
D147/G148
G149/P149
K153/K154
E168/D169
D184/G185
A198/K199
K199/K200
Q203/L204
N220/E221
E221/D222

Figure 8; a hand-annotated map of amino acid sequence for the mCherry amino acid sequence translated from the gene in pCT
from Geneious. Annotated with insertions sites (shaded arrow and vertical line), 𝛽-sheet (horizontal bracket and S#), and 𝛼helix (horizontal bracket and 𝛼#) locations

Having identified the desired insertion sites for the TEV Protease recognition sequence, work in
the nucleic acid domain could now begin. It is interesting and worth noting that Pavoor et al.
insertion sites Asp-102/Asp-103 and at Glu-172/Asp-173 are roughly analogous to mCherry
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insertion sites MC04 and MC11 respectively, with respect to the secondary and tertiary structure
of the protein.

Primer Design
All primer design activity took place in Geneious. The TEV-PRS, having an amino acid
sequence 7 residues in length, was coded for by a nucleic acid sequence 21 base pairs long.
Site-Directed Mutagenesis was selected as the first method to insert the sequence into the yomCherry gene. This method requires a pair of complementary primers, comprised of a segment
of the sequence immediately upstream of the insertion site, the site itself, and a segment
immediately downstream of the insertion site.

Figure 9; Amino acid (bottom) sequence for the TEV-PRS to be inserted into the mCherry protein, as well as the amino acid
sequence that codes for it.

In generating the forward primers, 20 bp upstream of the insertion site, followed by the insertion,
followed by 20 bp downstream were initially entered into Geneious. Since these primers will at
no point be themselves translated, there is no need to maintain the codon reading frame, so any
number of nucleotides can be present for the upstream and downstream binding regions. The
lengths of these upstream and downstream binding regions were varied in order to achieve the
desired predicted Tm value (melting temperature) of 55°C, such that it would function optimally
with the thermal cycle employed in the first mutagenesis approach; Site-Directed Mutagenesis.
Other factors taken into consideration when designing the primers were minimizing ΔG and
avoiding hairpin structures that could prevent annealing of primers to template DNA, which arise
from complementary ends. Oligonucleotide primers were all ordered from Integrated DNA
Technologies.

Figure 10; Forward (left) and Reverse (right) primers for MC03 in predicted thermostable conformation in Geneious; while there
is a significant intrabonding occurring, the oligonucleotide conformation represented here have free ends, and can thus function
as primers

The first four pairs primers ordered were the forward and reverse primers for insertion sites MC[02,06,09,11].
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Table 2; Forward and Reverse Primer Sequences for MC01-MC16 wherein the direction of the primer is indicated by the prefix F
or R in front of the insertion site name
F MC01
R MC01
F MC02
R MC02
F MC03
R MC03
F MC04
R MC04
F MC05
R MC05
F MC06
R MC06
F MC07
R MC07
F MC08
R MC08
F MC09
R MC09
F MC10
R MC10
F MC11
R MC11
F MC12

GAAGGTGAAGGTAGACCATACGAAAATTTGTATTTTCAAGGTGAAGGTACCCAAACCGC
GCGGTTTGGGTACCTTCACCTTGAAAATACAAATTTTCGTATGGTCTACCTTCACCTTC
GCTAAGTTGAAGGTCACCAAGGAAAATTTGTATTTTCAAGGTGGTGGTCCATTGCCATT
AATGGCAATGGACCACCACCTTGAAAATACAAATTTTCCTTGGTGACCTTCAACTTAGC
TTGAAGTTGTCTTTCCCAGAAGAAAATTTGTATTTTCAAGGTGGTTTCAAGTGGGAAAGAGT
ACTCTTTCCCACTTGAAACCACCTTGAAAATACAAATTTTCTTCTGGGAAAGACAACTTCAA
AAGAGTCATGAACTTCGAAGATGAAAATTTGTATTTTCAAGGTGGTGGTGTCGTCACC
GGTGACGACACCACCACCTTGAAAATACAAATTTTCATCTTCGAAGTTCATGACTCTT
CCAAGATTCTTCTTTGCAAGATGAAAATTTGTATTTTCAAGGTGGTGAATTCATTTACAAGGTCAA
TTGACCTTGTAAATGAATTCACCACCTTGAAAATACAAATTTTCATCTTGCAAAGAAGAATCTTGG
AGGTACCAACTTCCCATCTGAAAATTTGTATTTTCAAGGTGATGGTCCAGTCATGCAAA
TTTGCATGACTGGACCATCACCTTGAAAATACAAATTTTCAGATGGGAAGTTGGTACCT
GTACCAACTTCCCATCTGATGAAAATTTGTATTTTCAAGGTGGTCCAGTCATGCAAAAGA
TCTTTTGCATGACTGGACCACCTTGAAAATACAAATTTTCATCAGATGGGAAGTTGGTAC
CAACTTCCCATCTGATGGTGAAAATTTGTATTTTCAAGGTCCAGTCATGCAAAAGAAGAC
GTCTTCTTTTGCATGACTGGACCTTGAAAATACAAATTTTCACCATCAGATGGGAAGTTG
TGGTCCAGTCATGCAAAAGGAAAATTTGTATTTTCAAGGTAAGACCATGGGTTGGGAA
TTCCCAACCCATGGTCTTACCTTGAAAATACAAATTTTCCTTTTGCATGACTGGACCA
TTCTGAAAGAATGTACCCAGAAGAAAATTTGTATTTTCAAGGTGATGGTGCTTTGAAGGGT
ACCCTTCAAAGCACCATCACCTTGAAAATACAAATTTTCTTCTGGGTACATTCTTTCAGAA
GCAAAGATTGAAGTTGAAGGATGAAAATTTGTATTTTCAAGGTGGTGGTCACTACGATGC
GCATCGTAGTGACCACCACCTTGAAAATACAAATTTTCATCCTTCAACTTCAATCTTTGC
AAGACCACCTACAAGGCTGAAAATTTGTATTTTCAAGGTAAGAAGCCAGTCCAATTGC

25 nm
25 nm
25 nm
25 nm
25 nm
25 nm
25 nm
25 nm
25 nm
25 nm
25 nm
25 nm
25 nm
25 nm
25 nm
25 nm
25 nm
25 nm
25 nm
25 nm
25 nm
25 nm
25 nm

R MC12
F MC13
R MC13
F MC14
R MC14
F MC15
R MC15
F MC16
R MC16

GCAATTGGACTGGCTTCTTACCTTGAAAATACAAATTTTCAGCCTTGTAGGTGGTCTT
GACCACCTACAAGGCTAAGGAAAATTTGTATTTTCAAGGTAAGCCAGTCCAATTGCC
GGCAATTGGACTGGCTTACCTTGAAAATACAAATTTTCCTTAGCCTTGTAGGTGGTC
GCTAAGAAGCCAGTCCAAGAAAATTTGTATTTTCAAGGTTTGCCAGGTGCTTACAAC
GTTGTAAGCACCTGGCAAACCTTGAAAATACAAATTTTCTTGGACTGGCTTCTTAGC
AGTTGGATATTACCTCTCACAACGAAAATTTGTATTTTCAAGGTGAAGATTACACCATTGTCGAAC
GTTCGACAATGGTGTAATCTTCACCTTGAAAATACAAATTTTCGTTGTGAGAGGTAATATCCAACT
GGATATTACCTCTCACAACGAAGAAAATTTGTATTTTCAAGGTGAAGATTACACCATTGTCGAAC
GTTCGACAATGGTGTAATCTTCACCTTGAAAATACAAATTTTCTTCGTTGTGAGAGGTAATATCC

25 nm
25 nm
25 nm
25 nm
25 nm
25 nm
25 nm
25 nm
25nm

Mutation
Site Directed Mutagenesis (SDM)
The first mutation technique attempted was Site-Directed Mutagenesis (SDM) [15] [16]. This
particular version of the process of mutation began with the yeast-optimized mCherry gene
present in a pCT302 backbone. SDM using Phusion is more effective and less error-prone [17]
on smaller plasmids, so transfer of the yeast-optimized mCherry gene from pCT (7 kb) to pN3
(4.5 kb) needed to be performed. Restriction digest was performed upon pCT containing yomCherry using high-fidelity forms of NheI and BsrGI. The gene was isolated using gel
purification to separate the yo-mCherry gene/insert from the pCT backbone. The same restriction
sites are present in pN3, so the same was done with pN3 to separate and purify the backbone.
The isolated yo-mCherry gene was ligated into the pN3 backbone using T4 DNA Ligase.
The SDM was performed on the entire pN3 plasmid containing the yo-mCherry gene, and
yielded the same plasmid with an added mutation. The primers used contain the sequence to be
inserted, in this case the recognition site for TEV Protease, bracketed on either side by a
sequence complimentary to the template DNA upstream and downstream of the insertion site.
This primer and a complementary primer (referred to as Forward and Reverse primers) are used
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together. The complementary DNA bracketing the insertion allows for hybridization with the
template DNA. Phusion DNA Polymerase is then used to extend the plasmid along the entire
length of the template DNA. This is accomplished on both the forward and reverse strands,
yielding complementary strands which are broken in different places. The template DNA can be
eliminated by digestion using a DpnI, restriction enzyme which specifically targets methylated
DNA, so only DNA produced in vivo is affected. This distinguishes the template from the
mutated DNA because the template was originally produced in E. coli, and will be methylated,
while the newly synthesized DNA will not be. [18] This can be easily amplified in E. coli cells,
wherein cloning of the plasmid will result in uncut circular dsDNA.
SDM was attempted using the primers ordered for insertion sites MC-[02,06,09,11]. The
products were treated with DpnI and heat-shock transformed into TOP10 competent E. coli cells.
These cells were plated on LB-Kanamycin. Since pN3 carries kanamycin resistance, colonies
formed were assumed to carry the mutant plasmid. Two colonies were picked from each plate,
incubated in liquid LB media, and the resulting cells miniprepped. The resulting plasmid DNA
was sequenced at the UCONN Bioinformatics lab using Sanger sequencing. The results were
analyzed in Geneious software.
The attempt at site MC06 failed, as unwanted mutations were found. That at site MC02 was lost
due to low concentration of DNA. Sequencing of the mutated gene after attempting to insert at
MC09 and MC11 showed the SDM to have successfully inserted the TEV-PRS.

Figure 11; Visualization of Sanger sequencing results analyzed in Geneious software for attempted insertions at sites MC09 (top)
and MC11 (bottom) using Site-Directed Mutagenesis. Visual is zoomed to the insertion region.

Eight residues downstream, so instead of inserting at MC09 (K153/K154), the insertion was
made at (S161/S162). This insertion site will be referred to as MC0X.
Due to the high failure rate of the attempted insertion mutations made using SDM, combined
with the difficulty of involving another plasmid (pN3), a different mutagenesis method was
chosen; OE-PCR.
Overlap Extension PCR (OE-PCR)
The second mutation method attempted was Overlap-Extension PCR (OE-PCR) [11]. This
method is significantly more laborious and resource-intensive, but more reliable, and can be
performed successfully on genes in plasmids of greater size. The end product in this case is
linear double stranded DNA, the limits of which are determined by the primers used. The same
primers used in SDM can be used here, in conjunction with 2 more primers which flank the gene
of interest on either side.
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First, two PCR reactions are performed in parallel. Each consists of one of the SDM primers, and
one of the bracketing, or “sequencing”, primers. The “pcr ykc” thermal cycle is carried out upon
the template DNA along with DNA Polymerase and one of the two pairs of two plasmids,
resulting in the exponential amplification of the sequence including and between each pair of
primers. In this case, the forward sequencing primer for the pCT plasmid containing yeast
optimized mCherry (yo-mCherry) was paired with the reverse primer for a specific insertion site,
and the reverse sequencing primer with the forward primer for the insertion site. This produced 2
overlapping strands of DNA, which were complimentary only at the sites complimentary to the
insertion site primers. Combining these overlapping DNA segments with DNA Polymerase and
the forward and reverse sequencing primers in a “pcr ykc” thermal cycle results in the
amplification of the entire double stranded region between the sequencing primers, including the
mutation. The segment of DNA between the sequencing primer sites contained the protease
recognitions sites for NheI and BSRGI, and was therefore suitable for ligation back into pCT.
OE-PCR was attempted at sites MC-[01,03,04,05,06,07,12,13,14]. Beginning with pCT-yomCherry, the first round of PCR was performed by pairing the forward pCT insert sequencing
primer with the reverse mutagenic MC## primer, and the reverse pCT insert sequencing primer
with the forward mutagenic MC## primer. The products of these respective PCR reactions were
gel purified and recovered. The second round PCR was then conducted in duplicate, using the
products of both first round PCR’s as well as the forward and reverse pCT insert sequencing
primers. The resulting dsDNA was gel purified, recovered, and sequenced.
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Sequencing reveals insertions at sites MC-[01,04,07,12,14] to have been successful without
complication in either mutation or sequencing.

Figure 12; Visualization of Sanger sequencing results analyzed in Geneious software and aligned to the yo-mCherry gene for
attempted insertions at sites (from top to bottom) MC-[01,04 ,07,12,14] using OE-PCR. Visuals are zoomed to the insertion
region. Note that in the cases of MC-[04,05,07,12], the alignmentof the last nuclotide before the insertion, a thymine, is
misaligned to the last nucleotide of the insertion (also a thymine). This is only a software error, and does not reflect any
problems with the sequencing.
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Figure 13; Visualization of Sanger sequencing results analyzed in Geneious software and aligned to the yo-mCherry gene for
attempted insertions at site MC06 using OE-PCR. A; The insertion site where a frameshift mutation appears to have occurred in
the mutated sequence. B; the site of the apparent frameshift mutation. The presence of an extended, amorphous guanine peak
indicates a sequencing assembly error. C; the site of the apparent frameshift mutation after the added guanine residue is
manually removed. D; The insertion site where the apparent frameshift mutation has been repaired through manual deletion of
the added guanine. (Note that in the cases of the MC06, the alignmentof the last nuclotide before the insertion, a thymine, is
misaligned to the last nucleotide of the insertion (also a thymine). This is only a software error, and does not reflect any
problems with the sequencing.)

Figure 14; Visualization of Sanger sequencing results analyzed in Geneious software and aligned to the yo-mCherry gene for
attempted insertions at site MC03 using OE-PCR. Top; TEV-PRS Insertion site, and proximal location of an apparent unwanted
insertion mutation has occurred, resulting in a frameshift mutation. Bottom; The same site following manual deletion of the
unwanted 1bp insertion mutation, revealing an otherwise successful MC03 insertion.
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Figure 15; Visualization of Sanger sequencing results analyzed in Geneious software and aligned to the yo-mCherry gene for
attempted insertions at site MC05 using OE-PCR. While the mutation region itself (top) confirms a successful OE-PCR insertion,
downstream on the gene, the results for region between residues I212 and T217 (inclusive) is extremely noisy. Based on the
results, expected residue I216 was predicted by Geneious to be S216 because the second base in the codon was interpreted to be
a guanine instead of a thymine. This base was the last one in a buildup of noise, and significant peaks were present for both
thymine and guanine. This was likely a sequencing error due to contamination or presence of an air bubble.

Figure 16; Visualization of Sanger sequencing results analyzed in Geneious software and aligned to the yo-mCherry gene for
attempted insertions at site MC13 using OE-PCR. While the mutation itself (top) confirms a successful OE-PCR insertion, just
upstream of the insertion, a 2bp deletion mutation appears to have occurred. Additionally, upstream of the mutation, Geneious
has predicted a thymine based upon sequencing results instead of the expected cytosine. There are peaks indicating both, and
the base is flanked by two thymines on either side, so it is likely due to noise.
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Expression
The successfully mutated plasmids needed to be expressed in surface display yeast to see if the
mutant mCherry protein demonstrated fluorescence. The gene had been successfully inserted into
pCT302, in which tryptophan synthase were also present. The purified plasmid was transformed
into yeast EBY100 surface display yeast using METHOD. Transformed yeast was incubated in
SD-CAA media which is deficient in Tryptophan to select for successfully transformed cells.
These cells were centrifuged to their media were switched to SG-CAA, which is identical except
that it replaces glucose with galactose as a carbon source. The EBY100 yeast contains the GAL
operon, as well as an inserted GAL-regulated AGA1 surface display anchor protein. The
introduction of galactose induces the expression of this gene, as well as the expression of the
GAL-linked aga2-mCherry complex in pCT. As the cells are incubated in the SG-CAA medium,
the aga1 and aga2-mCherry complex are expressed, bond, and embed in the cell wall for surface
display. These cells are imaged under a digital microscope and transferred to a computer where
the fluorescence in the resulting images can be quantified and compared to a control.

A

B

C

D

Figure 17; Fluorescence imaging and analysis; A: fluorescence imaging for the accidental insertion that occurred in attempting
MC09, now known as MC0X; B: fluorescence imaging from MC11; C: fluorescence imaging from the wild type yo-mCherry; D:
digitally analyzed version of image 8.C, wherein a fluorescent expression value was determined for each cell.
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Table 3; Results of fluorescence imaging and digital analysis, wherein samples 9A correspond to site MC0X

Sample

Colony Average
Count

Standard
Deviation

9A-1
9A-2
9A (avg)

72
100

209.331
220.761
215.046

60.265
60.335

11A-1
11A-2
11A (avg)

180
156

526.183
467.523
496.853

285.981
245.713

yoCh1
yoCH2
yoCh (avg)

190
85

501.775
304.005
606.896
339.688
554.3355

700

Average Fluorescence Units per Colony

Plate 1

Plate 2

Average

600
500
400
300
200
100
0

9A

11A

Insertion Site

yomCh
(Wild Type)

Figure 18; Graphical representation of the average fluorescence units per colony for the expressed yo-mCherry mutants and the
control on 2 individual plates as well as the average for said plates.

Kinard 21

Discussion
Mutation
Table 4; Mutation status for each site, wherein the numbers following “MC…” refer to the sites identified in Figure 7C

Insertion
MC01
MC02
MC03
MC04
MC05
MC06
MC07
MC08
MC09
MC10
MC11
MC12
MC13
MC14
MC15
MC16
MC0X

Status
Successful mutation with OE-PCR
Progress lost before sequencing could be performed successfully
Possible Successful mutation with OE-PCR; Resequencing needed (see Figure 14)
Successful mutation with OE-PCR
Possible Successful mutation with OE-PCR; Resequencing needed (see Figure 15)
Possible Successful mutation with OE-PCR; Resequencing needed (see Figure 13)
Successful mutation with OE-PCR
Not attempted
Not attempted1
Not attempted
Successful mutation with SDM
Successful mutation with OE-PCR
Apparent failed mutation with OE-PCR; Resequencing needed (see Figure 16)
Successful mutation with OE-PCR
Not attempted
Not attempted
Successful mutation with SDM

Figure 19; Visual map of mCherry structure annotated with the current status of each
1

Sequencing revealed insertion to have been made at an incorrect site denoted with a “?” in
Figure 19. The accidental insertion site was made due to a clerical error in primer design, and is
present between two pleated sheets on the side of the cylindrical structure. This site is to be
referred to as MC0X.
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The mutations attempted were sequenced to find varying results. Site Directed Mutagenesis has
yielded 2 confirmed successes and one confirmed failure. OE-PCR, however, has produced at
least 5 confirmed successful mutations, likely as many as 8, and one apparent failure. Both
methods, SDM and OE-PCR, have proven viable mutagenesis techniques. However, failures
have been encountered in both cases. The failures may have occurred due to several causes.
Occurrence of other mutations may be due to sequencing failure or due to the inherent likelihood
of mutation during transcription at the low concentrations present during the beginning stages of
thermal cycling. The actual presence of mutations can only be determined by resequencing.
Based upon the outcome of the experimentation described in this report, SDM has at best a much
higher error rate than OE-PCR. This is due to the much larger amount of genetic data processed
during the extension phase; while OE-PCR only requires the extension of a primer to an end
point within the gene, in this case not more than 1kb, SDM requires the primers to be extended
around entire plasmid each cycle, over 4 kb.
With regard to procedure, both methods have significant advantages and disadvantages. SDM, in
theory, does not require a ligation step; the entire mutation can be achieved through thermal
cycling followed by amplification in bacteria and miniprep. In the case of this experiment,
however, this advantage did not apply, due to constraints later on in the experiment. Both pCT
and pN3 were needed, as the gene was initially present in pCT, and needed to be returned to pCT
for expression in yeast, but SDM could not be performed directly on pCT due to its size. This
added the double digest and ligation steps both before and after SDM was performed. pCT, on
the other hand, is as labor intensive both in theory as in practice. The technique requires two
independent PCR steps, each followed by gel purification and recovery, and finally double digest
and ligation back into the pCT backbone.
Due to the significantly lower error rate and the similar amount of work required for both
techniques under these circumstances, OE-PCR is the preferred technique for the insertion of the
TEV-PRS into the to-mCherry gene followed by yeast surface display.
The insertion at site MC0X occurred due to a clerical error when designing primers. While not
originally identified as a potential insertion site, the site satisfies some of the conditions laid out
in the Theory section of this report, in that it does not disturb secondary structure. While it is not
present in a loop connecting slats or helical core of the barrel-structure, it does connect two betasheets which make up a single slat, disrupting tertiary structure, but not secondary.
Structurally, this mutation is very intriguing, as the conformation may be analogous to a broken
slat in the barrel structure being propped outward, slightly warping the entire structure. The site
appears plausible for further investigation.

Expression
The fluorescence results are the only quantitative results from the entire body of lab work.
The sought after mutant, as described in the Theory section, would exhibit minimal or no
fluorescence before cleavage, and significant fluorescence after cleavage. Of the two sites
expressed, MC11 and MC0X, both exhibited fluorescence. MC11 displayed nearly fluorescence
that was not statistically different from the wild-type, indicating that this insertion site is not
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suitable for use as an in vivo protease sensor, as cleavage would at best result in a minor increase
in fluorescence. The second site, MC0X, presented with a substantial reduction in fluorescence,
of greater than 50%. While this is not as great a reduction as desired, it is currently the closest to
the sought after mutant.

Conclusion
It is difficult to draw conclusions from an incomplete research project. Being that this thesis
functions more as a progress report than a conclusive research paper, most of the take-away
pertains to future steps. Regarding the seventeen identified sites, the current state of the research
project is as follows:
•

•

•

•

Neither of the two successfully expressed mutations exhibited the desired lack of
fluorescence. One, however, which was not initially desired, exhibited a reduction in
fluorescence of greater than 50%.
At least five additional insertions have been successfully made and confirmed with
sequencing, with an additional three that require resequencing to confirm sequencing
error, and these are ready for expression in yeast.
Progress on two insertion sites attempted has been lost due to procedural error. Primers
for MC09 should be redesigned to target the intended site, and insertion MC02 should be
attempted again using OE-PCR.
Primers for the remaining four identified insertion sites have not been ordered, in
addition to one redesigned pair of primers for site MC09.

In summary, moving forward, all successfully mutated sequences should be expressed in yeast.
The remaining insertion sites should be attempted using OEPCR, as this technique requires
comparable labor and is far more reliable. All successfully mutated versions of the yo-mCherry
gene should be expressed in yeast, and then introduced to TEV protease to test for real-time in
vivo viability as protease sensors. Finally, it may be interesting and useful to investigate the
structure of the mutated mCherry-MC0x and others using X-Ray crystallography.
The results thus far indicate that the project shows promise, since the expressed mutations thus
far have exhibited reductions in fluorescence. Other undergraduate research assistants in Dr.
Yongku Cho’s lab will continue pursuit of the desired mutation. Research on the project thus far
was performed under instruction of Dr. Cho by undergraduates Kathryn Frances, Krystyna
Kapalczynski, Hamze Mah, Caroline Olesiak, Steven Rodriguez, Moe Uddin, and myself. Work
will be carried forward by Hamze Mah, Kathryn Frances, and others in the lab, as all others once
assigned to the project have since graduated.
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TEV-PRS - Tobacco Etch Virus Protease Recognition Site
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GFP – Green Fluorescent Protein
RFP – Red Fluorescent Protein
yo-mCherry – Yeast Optomized m(onomeric)Cherry

